The Journal of Allergy and Clinical Immunology
Volume 117, Issue 1 , Pages 67-71, January 2006

Neurotrophins and asthma: Novel insight into neuroimmune interaction

  • Wolfgang Andreas Nockher, MD, MSc

      Affiliations

    • Corresponding Author InformationReprint requests: Wolfgang A. Nockher, MD, MSc, Abteilung Klinische Chemie und Molekulare Diagnostik, Klinikum der Philipps-Universität Marburg, Baldingerstrasse, 35033 Marburg, Germany.
  • ,
  • Harald Renz, MD

From the Department of Clinical Chemistry and Molecular Diagnostics, University Hospital, Philipps-Universität Marburg

Received 23 February 2005; received in revised form 8 August 2005; accepted 15 August 2005. published online 04 October 2005.

Marburg, Germany

There is increasing evidence that neuronal dysfunction and dysregulation contribute to the pathogenesis of allergic asthma. Many functional aspects of peripheral neurons strongly depend on the activity of neurotrophins, a family of mediators originally defined by their neuronal growth activity. More recently, it has been discovered that neurotrophins (eg, nerve growth factor, brain-derived neurotrophin factor, and neurotrophin 3) have profound activities on various immune cells involved in the pathogenesis of allergic disease. Furthermore, immune cells themselves can produce neurotrophins under certain conditions, and the levels of neurotrophins, as well as neurotrophic activities, are strongly upregulated in allergic conditions. Animal data demonstrate that a number of pathomechanisms controlling allergic diseases are directly related to neurotrophin function, including the development of airway hyperresponsiveness. These findings now lead to a much better understanding concerning the regulatory loop between immunologic and neurogenic dysregulation. In this review we will provide an overview of how neurotrophins connect the pathobiology of airway inflammation and hyperresponsiveness, which are the hallmarks of allergic asthma.

Key words: Asthma, allergy, neurotrophins, airway inflammation, airway hyperresponsiveness, neuroimmune interaction

Abbreviations used: AHR, Airway hyperresponsiveness, BALF, Bronchoalveolar fluid, BDNF, Brain-derived neurotrophic factor, NGF, Nerve growth factor, NT-3, Neurotrophin 3, NT-4/5, Neurotrophin 4/5, Trk, Tropomyosin-related tyrosine kinase

 

 Guest editor: William W. Busse, MD

 Disclosure of potential conflict of interest: H. Renz has consultant agreements with Allergopharma and DPC, has received grants from DFG and EU, and is on the speakers' bureau for Allergopharma and ALK-Sherax. W. A. Nockher—none disclosed.

PII: S0091-6749(05)01914-7

doi:10.1016/j.jaci.2005.08.029

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 1 , Pages 67-71, January 2006